β- And α-Thalassemia Intermedia in Basra, Southern Iraq

REFERENCES

• Giardina PJV, Forget BG. Thalassemia syndromes. In: Hoffman R, Shattil SJ, Furie B, Silberstein LE, McGlave P, Eds. Hoffman Hematology: Basic Principles and Practice, 5th ed. Philadelphia: Churchill Livingstone. 2008:606–632.
   Google Scholar
• Modell B, Darlison M. Global epidemiology of hemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487.
   PubMed Web of Science ®Google Scholar
• Al-Allawi NA, Al-Dousky AA. Frequency of haemoglobinopathies at premarital health screening in Dohuk, Iraq: implications for a regional prevention programme. East Med Health J. 2010;16(4):381–385.
   PubMedGoogle Scholar
• Yahya HI, Khalel KJ, Al-Allawi NA, Helmi F. Thalassaemia genes in Baghdad, Iraq. East Med Health J. 1996;2(2):315–319.
   Google Scholar
• Hassan MK, Taha JY, Al-Naama LM, Widad NM, Jasim SN. Frequency of haemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in Basra. East Med Health J. 2003;1(2):1–9.
   Google Scholar
• Adams RJ, Brambilla D. Genetic disorders of hemoglobin. In: Hoffbrand AV, Moss PA, Pettit IE, Eds. Essential Hematology, 5th ed. Malden: Blackwell Publishing Company. 2006:72–84.
   Google Scholar
• David J. Hemoglobin and the inherited disorders of globin synthesis. In: Hoffbrand AV, Catovsky D, Tuddenham EG, Eds. Postgraduate Hematology, 5th ed. Malden: Blackwell Publishing Company. 2005:85–89.
   Google Scholar
• Fucharoen S, Viprakasit V. Hb H disease: clinical course and disease modifiers. Hematology Am Soc Hematal Educ Program. 2009:26–34.
   Google Scholar
• Taher A, Musallam KM, Cappellini MD. Optimal management of thalassaemia intermedia. Br J Haematol. 2011;152(5):512–523.
   PubMed Web of Science ®Google Scholar
• Camaschella C, Cappellini MD. Thalassemia Intermedia. Haematologica. 1995;80(1):58–68.
   PubMed Web of Science ®Google Scholar
• Rachmilewitz EA, Giardina PJV. How I treat thalassemia? Blood. 2011;118(13):3479–3488.
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics Centers for Disease Control (CDC). PedNSS Health Indicators. 2009. http://www.cdc.gov/pednss/what_is/pednss_health_indicators.html (accessed February 7 2012.)
   Google Scholar
• Krebs NF, Primak LE. Obesity. In: Kliegman RM, Jenson HB, Marcdante KJ, Behrman RE, Eds. Nelson Essentials of Pediatrics, 5th ed. Philadelphia: Elsevier Saunders. 2006:140–142.
   Google Scholar
• Kushner RF. Evaluation and management of obesity. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Eds. Harrison’s Principles of Internal Medicine, 17th ed. New York: McGraw-Hill Companies. 2007:468–472.
   Google Scholar
• Taher A, Musallam KM, Karimi M, Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010;115(11):1886–1893.
   PubMedGoogle Scholar
• Cappellini MD, Musallam KM, Taher A. Thalassemia Intermedia an update. Mediterr J Hematol Infect Dis. 2009;1(1):625–31.
   Google Scholar
• McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 2002;285 (26):1441–1446.
   Google Scholar
• Cappellini MD, Musallam KM, Cesaretti C, Taher A. Thalassemia intermedia. In: Beaumont C, Beris P, Beuzard Y, Brugnara C, Eds. Disorders of Erythropoiesis, Erythrocytes and Iron Metabolism. Genoa:Forum Service Editore. 2009:286–309.
   Google Scholar
• Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10(1):42.
   PubMedGoogle Scholar
• Fattoum S. Evolution of hemoglobinopathy prevention in Africa: results, problems and prospect. Mediterr J Hemat Infect Dis. 2009;1(1):e2009005.
   PubMedGoogle Scholar
• Hamamy H, Al-Hait S, Alwan A, Ajlouni K. Jordan: communities and community genetics. Community Genet. 2007;10(1):52–60.
   PubMedGoogle Scholar
• Hamamy H. Consanguineous marriages; preconception consultation in primary health care settings. J Community Genet. 2012;3(3):185–192.
   PubMedGoogle Scholar
• Alwan A, Modell B. Community control of genetic and congenital disorders. World Health Organization. Eastern Mediterranean Regional Office Technical Publication, Series 24. 1997:64–66.
   Google Scholar
• www.consang.net/global prevalence. Accessed January 6 2013.
   Google Scholar
• Ankra-Badu GA, Al-Jama A, Al Kadim Y. Hemoglobin H disease in the AL-Qatif region of Saudi Arabia. Ann Saudi Med. 2001;21(5–6):308–311.
   PubMed Web of Science ®Google Scholar
• Qadri MI, Islam SA. Hemoglobin H disease in the eastern region of Saudi Arabia. Saudi Med J. 2000;21(7):666–671.
   PubMedGoogle Scholar
• Venugopal S, Dhuri S, Al Jabal KB, Shaju A. Hemoglobin H disease in Muscat, Oman – A 5 year study. Oman Med J. 2008;23(2):82–85.
   PubMedGoogle Scholar
• Karamifar H, Karimi M, Amirhakimi GH, Badiei M. Endocrine function in thalassemia intermedia. Int J Biomed Sci. 2006;2(3):236–340.
   PubMedGoogle Scholar
• Chui DHK, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003;101(3):791–800.
   PubMed Web of Science ®Google Scholar
• Laosombat V, Viprakasit V, Chotsampancharoen T, Clinical features and molecular analysis in Thai patients with Hb H disease. Ann Hematol. 2009;88(12):1185–1192.
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Robbiolo L, Bottasso BM, Beuzard Y. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol. 2000;111(2):467–473.
   PubMed Web of Science ®Google Scholar
• Taher AT, Musallam KM, El-Beshlawy A, Age-related complications in treatment – naïve patients with thalassaemia intermedia. Br J Haematol. 2010;150(4):480–497.
   PubMedGoogle Scholar
• Vichinsky E. Complexity of α thalassemia: growing health problem with new approaches to screening, diagnosis, and therapy. Ann NY Acad Sci. 2010;1202:180–187.
   PubMed Web of Science ®Google Scholar
• Aessopos A, Kati M, Tsironi M, Polonifi E, Farmakis D. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia. Haematologica. 2006;91(3):e37–e38.
   Google Scholar